Free Trial

20 Stocks to Sell Now - 1 of 20

 
 

GameStop (NYSE:GME)

Consensus Rating
Sell
Rating Score
1.0
Ratings Breakdown
0 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$10.00 (55.5% Downside)

About GameStop

GameStop logoGameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/11/2024WedbushLower Price TargetUnderperform ➝ Underperform$11.00 ➝ $10.00
6/12/2024WedbushLower Price TargetUnderperform ➝ Underperform$13.50 ➝ $11.00
5/17/2024WedbushBoost Price TargetUnderperform ➝ Underperform$5.60 ➝ $7.00
3/27/2024WedbushLower Price TargetUnderperform ➝ Underperform$6.00 ➝ $5.60
11/30/2023WedbushReiterated RatingUnderperform ➝ Underperform$6.00
9/7/2023WedbushLower Price TargetUnderperform ➝ Underperform$6.20 ➝ $6.00
9/1/2023WedbushReiterated RatingUnderperform ➝ Underperform$6.20
6/8/2023WedbushLower Price TargetUnderperform$6.50 ➝ $6.20
12/8/2022WedbushLower Price TargetUnderperform$6.00 ➝ $5.30
7/22/2022WedbushLower Price TargetUnderperform$30.00 ➝ $7.50
 

FDA’s hidden signal greenlights biotech winners — 97% of the time (Ad)

The FDA has started to quietly send out a signal … That has given investors a 97% chance of making money. Perhaps as soon as 9:30 a.m. tomorrow.

Click here to find out how you can get in before the FDA’s potential signal.